Skadden, Davis Polk lead on Hong Kong’s biggest biotech IPO this year(双语)
BY Ines Yang, Reuters |
Skadden, Arps, Slate, Meagher & Flom and Han Kun Law Offices are acting for Chinese biopharma company Innovent Biologics on its HK$3.3 billion ($421 million) listing on the Hong Kong Stock Exchange, with Davis Polk & Wardwell and Commerce & Finance Law Offices advising the underwriters.